{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:28:32Z","timestamp":1773804512152,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Diabetes mellitus (DM) and hyperglycemia are important risk factors for poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19). The aim of the present study was to analyze the factors associated with the composite outcome of the necessity of invasive mechanical ventilation (IMV) or admission to the intensive care unit (ICU) in subjects with severe COVID-19 infection treated with dexamethasone comparing patients with DM vs. patients without DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Research design and methods<\/jats:title><jats:p>An observational retrospective cohort study was performed, including hospitalized subjects with a diagnosis of SARS-CoV-2 pneumonia. Inclusion criteria were: age \u226518 years old with severe COVID-19 disease requiring daily intravenous 6 mg dexamethasone treatment for 10 days. Exclusion criteria were: &amp;lt;18 years old, non-severe illness and\/or patients in charge of ICU. Variables related to clinical and analytical parameters, glycemic control, acquired-hospital superinfections, mortality, IMV requirement, ICU admission and length of stay were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred and nine individuals with COVID-19 disease treated with dexamethasone were included. One hundred twenty-five out of these subjects (59.8%) were patients with DM. Overall, from the 209 subjects, 66 (31.6%) required IMV or were admitted to the ICU, with significant differences between patients with DM (n=50) vs. patients without DM (n=16) (76% vs. 24%, p=0.002). Among the group of subjects with DM (n=125), those who required IMV or were admitted to the ICU showed higher serum concentrations of C-reactive protein, interleukin-6, D-dimer, ferritin and pro-calcitonin and significantly lower serum concentrations of albumin compared to those who did not require IMV or were not admitted to the ICU. Besides, between these two groups of patients with DM, we observed no differences in glycemic parameters, including median capillary blood glucose values, glycosylated hemoglobin, coefficient of variability and hypoglycemic episodes. In the multinomial analysis, factors independently associated with the composite outcome of IMV or admission to the ICU in the insulin-treated group were the National Early Warning Score (NEWS) 2 score (OR 1.55 [1.17-2.17], p=0.005) and the presence of hospital-acquired superinfections (OR 35.21 [5.11-386.99], p=0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our study, parameters related to glycemic control were not associated with IMV requirement nor admission to the ICU in patients with DM and severe COVID-19 disease receiving daily 6 mg of dexamethasone for 10 days. However, hospital-acquired superinfections and disease severity at admission were independent factors associated with this composite outcome.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1009028","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:21:01Z","timestamp":1671711661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Sol","family":"Batule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carme","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Juli\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Egea-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Reyes-Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Mateu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: Relevance for immunopathology of SARS-CoV-2","volume":"53","author":"Gubernatorova","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e14378","DOI":"10.1111\/dme.14378","article-title":"Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes","volume":"38","author":"Rayman","year":"2021","journal-title":"Diabetes Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis","volume":"37","author":"Falciglia","year":"2009","journal-title":"Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SLA.0000000000000688","article-title":"Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes","volume":"261","author":"Kotagal","year":"2015","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B12","article-title":"COVID-19: Management of adults with acute illness in the outpatient setting","author":"Cohen","year":"2022","journal-title":"In: Up to Date"},{"key":"B13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00526-2","article-title":"New insights into the cell- and tissue-specificity of glucocorticoid actions","volume":"18","author":"Quatrini","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01114-x","article-title":"Telemonitoring, telemedicine and time in range during the pandemic: Paradigm change for diabetes risk management in the post-COVID future","volume":"12","author":"Danne","year":"2021","journal-title":"Diabetes Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09678-6","article-title":"Basic mechanisms of SARS-CoV-2 infection. what endocrine systems could be implicated","volume":"23","author":"Soldevila","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"B17","unstructured":"COVID-19 clinical management: living guidance2021"},{"key":"B18","doi-asserted-by":"publisher","first-page":"ciaa478","DOI":"10.1093\/cid\/ciaa478","article-title":"Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7861\/clinmedicine.19-3-260","article-title":"The national early warning score 2 (NEWS2)","volume":"19","author":"Smith","year":"2019","journal-title":"Clin Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e051237","DOI":"10.1136\/bmjopen-2021-051237","article-title":"Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study","volume":"11","author":"Ortega","year":"2021","journal-title":"BMJ Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-021-00083-w","article-title":"The role of co-infections and secondary infections in patients with COVID-19","volume":"13","author":"Feldman","year":"2021","journal-title":"Pneumonia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"103492","DOI":"10.1016\/j.resp.2020.103492","article-title":"Pros and cons of corticosteroid therapy for COVID-19 patients","volume":"280","author":"Mattos-Silva","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2012.12.016","article-title":"The ability of the national early warning score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death","volume":"84","author":"Smith","year":"2013","journal-title":"Resuscitation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2020.10.039","article-title":"The performance of the national early warning score and national early warning score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"159","author":"Kostakis","year":"2021","journal-title":"Resuscitation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.resuscitation.2020.08.124","article-title":"Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores","volume":"156","author":"Covino","year":"2020","journal-title":"Resuscitation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/23744235.2020.1784457","article-title":"Predictive value of national early warning score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection","volume":"52","author":"Gidari","year":"2020","journal-title":"Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jaci.2020.07.009","article-title":"IL-6\u2013based mortality risk model for hospitalized patients with COVID-19","volume":"146","author":"Laguna-Goya","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0287","article-title":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a Large primary care cohort study","volume":"41","author":"Critchley","year":"2018","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.83.s1.06","article-title":"Inpatient hyperglycemia management: A practical review for primary medical and surgical teams","volume":"83","author":"Lansang","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1857","article-title":"Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: A multicenter, retrospective hospital-based analysis","volume":"44","author":"Klonoff","year":"2021","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2020.11.014","article-title":"Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes","volume":"33","author":"Yu","year":"2021","journal-title":"Cell Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2020.07.003","article-title":"En nombre del grupo SEMI-COVID-19 network. clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 registry","volume":"220","author":"Casas-Rojo","year":"2020","journal-title":"Rev Clin Esp"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2022-002363","article-title":"COVID-19 pneumonia in patients with impaired fasting glucose, newly diagnosed diabetes and pre-existing diabetes: a tertiary center experience","volume":"70","author":"Boyuk","year":"2022","journal-title":"J Investig Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1009028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T12:21:05Z","timestamp":1671711665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1009028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":37,"alternative-id":["10.3389\/fendo.2022.1009028"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1009028","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1009028"}}